Skip to content
Screener

Kailera Therapeutics KLRA EBITDA

EBITDA at other companies

Thor Industries logo
Thor IndustriesTHO
$189.77M-9.9%
Ambarella logo
AmbarellaAMBA
-$13.05M+31.7%
PVH logo
PVHPVH
$186.9M+171%
Brookdale Senior Living logo
Brookdale Senior LivingBKD
$128.72M+3.7%
Academy Sports and Outdoors logo
Academy Sports and OutdoorsASO
$105.41M+6.0%
Helios Technologies logo
Helios TechnologiesHLIO
$45M+36.4%

Other financials

Income statement

See full
Operating income-$84.7M-314%
Net income-$78.9M-339%
EPS (diluted)-$3,650.00+79.7%

Balance sheet

See full
Cash & equivalents$111.8M+9.9%
Total debt$10.5M—
Total equity-$432.1M-83.7%
Total assets$624.8M—

Cash flow

See full
Operating cash flow-$68.3M-275%

Valuation

See full
Market cap$2.44B-15.8%
Enterprise value$2.34B—

Returns & leverage

See full
Debt / equity-0×—
Current ratio9.7×—

Where this comes from

Calculated from Kailera Therapeutics’s reported figures.

−$84.7Moperating income+$101.0Kdepreciation and amortization cf=-$84.56M

The source filing: Kailera Therapeutics’s 10-Q, filed May 26, 2026. Open the filing →

Filed
May 26, 2026, 4:29 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-239417

FAQ

What is Kailera Therapeutics's EBITDA?
Kailera Therapeutics (KLRA) reported EBITDA of -$84.56M in Q1 2026.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Kailera Therapeutics's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude